# Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

> **NCT06734702** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 497 (estimated)

## Conditions studied

- Neoadjuvant Therapy
- Concurrent Chemoradiotherapy
- Immunotherapy
- Locally Advanced Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Neoadjuvant therapy
- **RADIATION:** Hypo-RT and concurrent chemotherapy
- **RADIATION:** CFRT and concurrent chemotherapy
- **DRUG:** Consolidative immunotherapy

## Key facts

- **NCT ID:** NCT06734702
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-30
- **Primary completion:** 2028-11-29
- **Final completion:** 2028-11-29
- **Target enrollment:** 497 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06734702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06734702, "Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06734702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*